Table 1.
Characteristics | Age 0–5 years | Age 6–19 years | p-value |
---|---|---|---|
n = 49 | n = 1687 | ||
Median age (range) | 4 years (0 – 5) | 14 years (6 – 19) | |
Male | 46.9% (23) | 56.4% (952) | 0.19 |
Stage | |||
Metastatic | 12.2% (6) | 17.7% (299) | 0.48 |
Localized | 77.6% (38) | 75.2% (1268) | |
Unknown | 10.2% (5) | 7.1% (120) | |
Histology | |||
Osteosarcoma, NOS | 79.6% (39) | 78.7% (1327) | 0.098* |
Chondroblastic | 8.2% (4) | 11.9% (200) | |
Fibroblastic | 2% (1) | 4.1% (69) | |
Telangiectatic | 10.2% (5) | 2.9% (50) | |
Other histologies | 0% | 2.4% (41) | |
Site | |||
Upper limb | 24.5% (12) | 11.2% (189) | 0.006 |
Lower limb | 59.2% (29) | 78% (1315) | |
Other sites | 16.3% (8) | 10.9 (183) | |
Race/Ethnicity | |||
White non-Hispanic | 53.1% (26) | 54.8% (924) | 0.43 |
Asian non-Hispanic | 4.1% (2) | 9.8% (165) | |
Black non-Hispanic | 14.3% (7) | 14.2% (240) | |
White Hispanic | 20.4% (10) | 16.9% (285) | |
Unknown or Other | 8.2% (4) | 4.3% (73) | |
Year of diagnosis | |||
1973 – 1977 | 6.1% (3) | 7.6% (128) | 0.76 |
1978 – 1982 | 12.2% (6) | 9.1% (153) | |
1983 – 1987 | 8.2% (4) | 8.7% (147) | |
1988 – 1992 | 16.3% (8) | 9.7% (164) | |
1993 – 1997 | 12.2% (6) | 14.2% (240) | |
1998 – 2002 | 20.4% (10) | 25.6% (431) | |
2003 – 2006 | 24.5% (12) | 25.1% (424) |
P-value reflects overall difference in histologic subtypes between age groups. P-value for difference in telangiectatic subtype compared to all other histologies between age groups was 0.017.